When Novo Nordisk, the Danish pharmaceutical company who created Ozempic, realized the drug helps with weight loss, they quickly pushed the FDA to approve higher doses of the drug as a treatment for obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 51.Sato H., Nomura S., Maebara K., Sato K., Tamba M., Bannai S
The reduction of cortisol plasma levels is a clear marker of the neuroendocrine modulation exerted by PVG, since patients with HA have usually cortisol plasma levels at the higher level from the normal range
2.5 Gastrointestinal Side Effects Common adverse effects during dose escalation include: Nausea Vomiting Diarrhoea Early satiety Persistent gastrointestinal symptoms may increase the risk of: Reduced caloric intake Reduced protein intake Electrolyte imbalance Dehydration Most symptoms improve with gradual titration and adaptation
Have a plan for monitoring and response